Skip to main content
. 2018 Feb 23;13(2):e0192981. doi: 10.1371/journal.pone.0192981

Table 2. Hemodynamic parameters preischemically and during postischemic-reperfusion.

n Baseline Reperfusion
2 min 5 min 10 min 20 min 30 min 60 min 120 min
LVDP (mmHg)
6 Weeks non-DM control 11 137 ± 3 5 ± 1 6 ± 1 7 ± 1 32 ± 5 59 ± 3 60 ± 2 48 ± 2
non-DM IPC 8 132 ± 4 11 ± 3 27 ± 6 49 ± 8 83 ± 6 79 ± 5 70 ± 5 57 ± 5
T2DM control 10 155 ± 6 7 ± 2 7 ± 2 7 ± 2 12 ± 4 26 ± 6 33 ± 3 25 ± 3
T2DM IPC 8 156 ± 7 7 ± 2 9 ± 2 10 ± 2 37 ± 4 50 ± 4 48 ± 2 37 ± 2
12 Weeks non-DM control 10 160 ± 4 5 ± 1 27 ± 3 20 ± 2 46 ± 6 61 ± 7 66 ± 6 55 ± 4
non-DM IPC 9 151 ± 7 13 ± 2 34 ± 5 39 ± 5 52 ± 6 64 ± 4 66 ± 4 51 ± 3
T2DM control 11 167 ± 6 9 ± 2 23 ± 3 28 ± 5 42 ± 6 61 ± 7 68 ± 3 54 ± 5
T2DM IPC 8 174 ± 7 7 ± 1 21 ± 5 24 ± 3 55 ± 6 74 ± 10 73 ± 4 70 ± 7
24 Weeks non-DM control 10 132 ± 8 5 ± 1 15 ± 3 12 ± 2 21 ± 8 30 ± 8 47 ± 4 40 ± 3
non-DM IPC 9 162 ± 4 13 ± 2 20 ± 5 12 ± 3 22 ± 6 13 ± 2 54 ± 4 53 ± 4
T2DM control 9 157 ± 7 11 ± 2 13 ± 3 16 ± 2 16 ± 4 22 ± 4 32 ± 6 22 ± 4
T2DM IPC 8 146 ± 1 9 ± 3 25 ± 7 40 ± 7 58 ± 8 68 ± 8 55 ± 8 56 ± 5
RPP (0.01xmmHgxmin-1)
6 Weeks non-DM control 11 373 ± 10 9 ± 1 12 ± 2 16 ± 3 71 ± 15 153 ± 12 166 ± 10 126 ± 7
non-DM IPC 8 298 ± 27 29 ± 10 81 ± 19 136 ± 21 213 ± 17 211 ± 22 194 ± 17 158 ± 17
T2DM control 10 333 ± 29 14 ± 4 13 ± 3 11 ± 2 21 ± 7 53 ± 12 76 ± 6 54 ± 9
T2DM IPC 8 347 ± 23 17 ± 5 23 ± 6 25 ± 5 92 ± 10 119 ± 12 126 ± 10 106 ± 5
12 Weeks non-DM control 10 473 ± 63 12 ± 2 55 ± 8 45 ± 7 107 ± 12 147 ± 16 160 ± 13 123 ± 11
non-DM IPC 9 308 ± 28 31 ± 5 79 ± 14 87 ± 16 115 ± 13 140 ± 12 174 ± 18 113 ± 13
T2DM control 11 272 ± 23 20 ± 3 55 ± 12 54 ± 13 66 ± 9 93 ± 13 115 ± 10 94 ± 12
T2DM IPC 9 203 ± 14 15 ± 2 39 ± 10 47 ± 6 74 ± 10 129 ± 19 151 ± 17 84 ± 12
24 Weeks non-DM control 10 246 ± 18 11 ± 1 39 ± 9 32 ± 5 34 ± 11 59 ± 17 79 ± 10 67 ± 10
non-DM IPC 9 273 ± 27 34 ± 6 56 ± 13 35 ± 13 59 ± 16 34 ± 7 149 ± 15 124 ± 20
T2DM control 9 231 ± 25 22 ± 3 16 ± 4 16 ± 4 15 ± 4 22 ± 5 32 ± 7 34 ± 7
T2DM IPC 8 184 ± 25 16 ± 4 31 ± 7 51 ± 13 67 ± 14 82 ± 17 96 ± 23 123 ± 14
HR (bpm)
6 Weeks non-DM control 11 273 ± 4 198 ± 19 216 ± 11 230 ± 10 213 ± 16 255 ± 10 272 ± 10 261 ± 8
non-DM IPC 8 225 ± 19 244 ± 10 292 ± 13 287 ± 13 258 ± 15 267 ± 21 278 ± 16 279 ± 12
T2DM control 10 217 ± 18 194 ± 17 225 ± 17 195 ± 23 201 ± 19 197 ± 9 231 ± 11 217 ± 10
T2DM IPC 8 226 ± 19 236 ± 15 237 ± 17 249 ± 11 252 ± 11 238 ± 19 265 ± 19 288 ± 6
12 Weeks non-DM control 9 292 ± 34 219 ± 20 205 ± 18 241 ± 31 246 ± 17 229 ± 8 231 ± 4 224 ± 7
non-DM IPC 9 209 ± 20 230 ± 12 230 ± 27 235 ± 27 230 ± 22 221 ± 18 264 ± 21 229 ± 13
T2DM control 11 166 ± 16 234 ± 16 236 ± 32 209 ± 26 170 ± 21 154 ± 12 170 ± 11 182 ± 25
T2DM IPC 8 123 ± 12 237 ± 14 231 ± 41 234 ± 35 147 ± 9 206 ± 30 219 ± 20 128 ± 28
24 weeks non-DM control 10 216 ± 13 244 ± 11 263 ± 16 268 ± 19 229 ± 31 222 ± 17 195 ± 29 189 ± 25
non-DM IPC 9 169 ± 16 270 ± 9 285 ± 22 269 ± 18 258 ± 34 237 ± 17 289 ± 7 291 ± 18
T2DM control 9 150 ± 17 224 ± 18 137 ± 22 109 ± 17 138 ± 27 121 ± 25 128 ± 27 177 ± 32
T2DM IPC 8 129 ± 16 205 ± 30 158 ± 35 119 ± 14 114 ± 14 117 ± 15 190 ± 36 232 ± 30

Preischemic hemodynamic variables in 6-, 12-, and 24-week-old non-DM rats (heterozygote (fa/+)) and DM ZDF rats (homozygote (fa/fa)) treated with control or IPC. LVDP: Left ventricular developed pressure, RPP: Rate-pressure-product, HR: Heart rate.

Data are mean ± SEM.